Lonza Group (FRA:LO3) Total Equity: €8,537 Mil (As of Dec. 2025)


FRA:LO3 Lonza Group Ltd FRA:LO3
81 GF Score
Price €593.20
GF Value €642.72
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Lonza Group Total Equity?

Lonza Group FRA:LO3 +1.64% 81 Total Equity is €8,537 Mil as of Dec. 2025. GuruFocus rates FRA:LO3 with a GF Score™ of 81/100 and a GF Value™ of €642.72 (Fairly Valued). The stock has 3 warning signs investors should review.

Lonza Group's total equity for the quarter that ended in Dec. 2025 was €8,537 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Lonza Group Total Equity Historical Data

* Premium members only.

The historical data trend for Lonza Group's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lonza Group Total Equity Chart

Lonza Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,439.04 10,806.96 10,086.15 10,055.56 8,536.79

Lonza Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,086.15 9,784.75 10,055.56 9,249.99 8,536.79
FRA:LO3
81GF Score
Lonza Group Ltd FRA:LO3
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lonza Group Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Lonza Group's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=19190.084-10653.299
=8,537

Lonza Group's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=19190.084-10653.299
=8,537

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €8,537 Mil mean?
Lonza Group (FRA:LO3) has a Total Equity of €8,537 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Lonza Group and its competitors.
Is Lonza Group's Total Equity too high?
Lonza Group's current Total Equity is €8,537 Mil. Overall, Lonza Group has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Lonza Group's Total Equity compare to TMO and DHR?
Lonza Group's Total Equity of €8,537 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Diagnostics & Research company?
A good Total Equity depends on the Medical Diagnostics & Research industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Lonza Group and its competitors. Lonza Group's current Total Equity is €8,537 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lonza Group stock overvalued right now?
Based on GuruFocus' analysis, Lonza Group (FRA:LO3) is currently considered Fairly Valued. The stock's GF Value™ is €642.72, compared to a current price of €593.20 — trading 7.7% below its estimated fair value. The current Total Equity is €8,537 Mil. Lonza Group's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Lonza Group (FRA:LO3), the current Total Equity is €8,537 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lonza Group (FRA:LO3) Overvalued in 2026?

Based on GuruFocus' analysis, Lonza Group stock appears to be undervalued. The current stock price of €593.20 is trading 7.7% below its estimated GF Value™ of €642.72. GuruFocus considers Lonza Group to be Fairly Valued.

Key valuation signals for FRA:LO3:

  • Total Equity: €8,537 Mil
  • GF Value™: €642.72 vs. price of €593.20 (7.7% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the FRA:LO3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lonza Group Business Description

Address Muenchensteinerstrasse 38, Basel, CHE, 4002
Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
81GF Score

Get the complete analysis for FRA:LO3

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€593.20
Price
€642.72
GF Value